Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Delivery
Return to: PBR Home | Drug Research | Drug Delivery | Suppliers

Softigel - Manufacturers of Softgel Pharmaceutical Products News

Softigel - Manufacturers of Softgel Pharmaceutical Products

Softigel invites you to join a Live Webinar on Stability Issues Related to Softgels
View press release
FDA successfully completed a 5-Day inspection of PROCAPS sites in Barranquilla with no Form 483 issued! PROCAPS S.A. is pleased to announce that the US Food and Drug Administration (FDA) completed an inspection of our quality system, manufacturing facilities, and labs thorough a 1-week GMP audit in our sites in Barranquilla, Colombia. The inspection confirmed the sites to be compliant with the principles and guidelines of Good Manufacturing Practice (GMP), and no Form 483 was issued. The US FDA authorities inspected the facilities from September 28th to October the 2nd, 2015 having originally inspected and approved the sites in 2009, and 2012. Another significant achievement that makes us very proud.
View press release
Redefining Innovation! Come and Gel with Us During CPhi Madrid Softigel by Procaps will be attending CPhi Worldwide in Madrid. Our team of experts will be delighted to sit with you and discuss mutual opportunities.
View press release
Stability Issues Related to Soft Gelatin Capsule Development Stability issues are a challenge and never ending concern for formulators. The reactivity of formulations depends on many factors but it is generally recognized that labile drugs in aqueous forms are sometimes the worst cases and in this regard, this should be a true statement for the development teams which work with SGC´s.
View press release
Extending Soft Gelatin Capsule Benefits to Novel Fixed Dose Combinations: Unigel Fixed dose combinations are desirable for several reasons such as different release profiles and guaranteeing patients´ compliance by reducing the daily intake of a drug product(s).
View press release